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Envenomations by Bothrops asper are often associated with complex and severe local
pathological manifestations, including edema, blistering, dermonecrosis, myonecrosis and
hemorrhage. The pathogenesis of these alterations has been investigated at the experi-
mental level. These effects are mostly the consequence of the direct action of zinc-
dependent metalloproteinases (SVMPs) and myotoxic phospholipases A2 (PLA2s). SVMPs
induce hemorrhage, blistering, dermonecrosis and general extracellular matrix degrada-
tion, whereas PLA2s induce myonecrosis and also affect lymphatic vessels. In addition, the
prominent vascular alterations leading to hemorrhage and edema may contribute to
ischemia and further tissue necrosis. The mechanisms of action of SVMPs and PLA2s are
discussed in detail in this review. Venom-induced tissue damage plays also a role in
promoting bacterial infection. A prominent inﬂammatory reaction develops as a conse-
quence of these local pathological alterations, with the synthesis and release of abundant
mediators, resulting in edema and pain. However, whether inﬂammatory cells and
mediators contribute to further tissue damage is not clear at present. Muscle tissue
regeneration after venom-induced pathological effects is often impaired, thus resulting in
permanent tissue loss and dysfunction. SVMP-induced microvessel damage is likely to be
responsible of this poor regenerative outcome. Antivenoms are only partially effective in
the neutralization of B. asper-induced local effects, and the search for novel toxin inhibitors
represents a potential avenue for improving the treatment of this serious aspect of
snakebite envenomation.
 2009 Elsevier Ltd. All rights reserved.1. Envenomations by Bothrops asper are characterized
by drastic local pathological effects
B. asper is responsible for the vast majority of snakebite
envenomations in Central America and in some regions of
northern South America (Bolan˜os, 1982; Gutie´rrez, 1995;
Otero et al., 2006). This is due to a number of factors, i.e. the
widespread distribution of this species in low-land humid
areas devoted to agricultural activities, the high capacity of
this species to adapt to altered environments, such as
agricultural ﬁelds and pastures (Savage, 2002; Solo´rzano,
2004), and the consequent close contact between B. asperx: þ506 2292 0485.
alante).
. All rights reserved.and humans in rural areas. In addition, B. asper is able to
deliver a relatively large volume of venom (Bolan˜os, 1972),
thus being capable of provoking severe envenomations.
The relevance of B. asper goes beyond human medicine,
since it is also responsible for a great number of enveno-
mations in domestic animals, particularly cattle, dogs and
horses (Villalobos, 2008).
Envenomations by B. asper are characterized by a prom-
inent and complex series of local pathological alterations,
which appear rapidly after the bite at the anatomical site
where venom is injected. Such effects include edema and
pain, hemorrhage, myonecrosis, blistering, and dermonec-
rosis (Picado, 1931; Bolan˜os, 1982; Gutie´rrez, 1995; Otero
et al., 2002; Warrell, 2004). Furthermore, local infection by
bacteria present in the mouth of the snake or in the skin of
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described in other Bothrops sp. envenomations aswell (Jorge
et al., 1994). The pathogenesis of local pathology induced by
B. asper venom has been the subject of many experimental
studies that have clariﬁed the mechanisms through which
toxins present in this venom inﬂict such a drastic and
complex pathological picture. The present work reviews this
information and highlights some unsolved issues that
demand further investigation.
2. Edema and pain
2.1. The synthesis and release of endogenous mediators play
a central role in edema, hyperalgesia and allodynia
Local edema and pain appear very rapidly after injection
of B. asper venom in experimental animals (Gutie´rrez and
Lomonte, 2003; Chaves et al., 1995; Chacur et al., 2001). The
time-course of edema in rodent footpad assays greatly
depends on the dose of venom injected. At low doses,
edema peaks within the ﬁrst hour and drops at later time
intervals (Lomonte et al., 1993). However, when higher
doses are administered, edema persists for more prolonged
time intervals (Gutie´rrez et al., 1980a; Lomonte et al., 1993;
Chaves et al., 1995). This probably reﬂects different
mechanisms in the genesis of ﬂuid imbalance in the tissues
which leads to edema. The pathophysiology of edema
formation induced by B. asper venom is multifactorial.
There is a direct damage onmicrovessels, i.e. capillaries and
venules, by the action of hemorrhagic toxins (see Section 3),
with the consequent extravasation. In addition, edema is
mediated by the action of inﬂammatorymediators, released
or synthesized in the course of envenomation, which
induce increments in the permeability of microvessels
(Gutie´rrez and Lomonte, 2003; Teixeira et al., 2003a).
Pharmacological studies in mice and rats have identiﬁed
a number of mediators involved in B. asper venom-induced
footpad edema, such as prostaglandins, nitric oxide and
others (Chaves et al., 1995, 2006; Olivo et al., 2007). This
agrees with observations performed with other Bothrops
sp. venoms (Bonta et al., 1979; Trebien and Calixto, 1989).
Similarly, the pharmacological basis of hyperalgesia and
allodynia induced by this venomhas been investigated, and
the involvement of various mediators, such as bradykinin
and leucotrienes, evidences a multifactorial mechanism in
the onset of pain (Chacur et al., 2001). Myotoxic phospho-
lipases A2 play a key role in B. asper venom-induced
hyperalgesia (Chacur et al., 2003). The pharmacological
mediation of edema and pain is covered in detail in another
contribution in this volume (see Teixeira et al., this issue).
2.2. Pathological effects on lymphatic vessels and their
possible role in the pathogenesis of edema
The observation that high doses of B. asper venom
provoke a long-standing edema suggests that pathological,
in addition to pharmacological, mechanisms may be at
work in these conditions, i.e. that pathological alterations
in the tissues and the vasculature are responsible for
a prolonged interstitial ﬂuid imbalance. It is possible that
pathological damage to microvessels may be responsiblefor this phenomenon, since venom drastically affects the
integrity of capillaries, venules and small arteries (Arce
et al., 1991; Moreira et al., 1992). Recent ﬁndings suggest
that a direct effect of the venom on collecting lymphatic
vessels may be also involved. When B. asper venom is
directly applied onto exposed mouse mesentery prepara-
tions and observed by intravital microscopy, there is a rapid
and marked reduction in the lumen of collecting
lymphatics, an effect associatedwith a halting in the ﬂow of
lymph in these vessels (Mora et al., 2008).
This effect on lymphatics was not reproduced when
a hemorrhagic metalloproteinase or a coagulant serine
proteinase was applied, thus evidencing that it is not the
consequence of clotting of ﬁbrinogen or extracellular
matrix degradation. Instead, the effect is reproduced when
a myotoxic phospholipase A2 (PLA2) homologue, myotoxin
II, is applied (Mora et al., 2008). In agreement, the effect
induced by crude B. asper venom was abrogated by fucoi-
dan, a polysaccharide inhibitor of myotoxins, but not by the
metalloproteinase inhibitor batimastat (Mora et al., 2008).
Myotoxin II was shown to lyse smooth muscle cells in
culture and it was suggested that the reduction in
lymphatic vessel lumen is the result of smooth muscle cell
membrane perturbation by myotoxins, with the conse-
quent calcium inﬂux and contraction of muscle cells of the
collecting lymphatic wall (Mora et al., 2008). The functional
consequences of this phenomenon are obvious, since an
adequate lymph ﬂow depends on the periodic contraction
of the lymphangions associated with the opening and
closure of the lymphatic valves (Schmid-Scho¨nbein, 2006).
Thus, if the vessel is permanently contracted, due to the
action of venom myotoxic PLA2s, the lymph ﬂow is halted.
Furthermore, if lymphatic smooth muscle cells are irre-
versibly damaged by the venom, as occurs in cell culture
conditions, then the pumping of lymph would be perma-
nently impaired. In agreement with these observations,
fucoidan was highly effective in the inhibition of B. asper
venom-induced mouse footpad edema (Mora et al., 2008).
Venom-induced vascular disturbances leading to edema
may contribute to the overall pathophysiology of envenoma-
tion in two additional ways: (a) the ﬂuid imbalance resultant
from these alterations represents a signiﬁcant displacement of
ﬂuid from the vascular compartment to the interstitial
compartment, thus contributing to the hypovolemia and
consequent hemodynamic alterations typical of severe enve-
nomations by viperid snakes (Warrell, 1996, 2004). (b) The
pronounced increment in interstitial ﬂuid in some muscle
compartments, such as the anterior tibial compartment, may
result in an increment in intracompartmental pressure. When
this pressure increases over 40mm Hg, a compartmental
syndrome may develop (Warrell, 1999), with the consequent
effect in the perfusion to distal regions and the onset of
ischemic damage (see Section 6.5).
3. Local hemorrhage
3.1. Zinc-dependent metalloproteinases are responsible for
local hemorrhagic effects
B. asper venom, and the majority of viperid venoms, are
rich sources of zinc-dependent proteinases, a group of
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alloproteinases, comprised by the snake venom metal-
loproteinases (SVMPs) and the ADAMs (A Disintegrin And
Metalloproteinase enzymes) (Fox and Serrano, 2005). All
hemorrhagic components isolated from viperid snake
venoms are SVMPs, although not all SVMPs are able to
induce hemorrhage (Fox and Serrano, 2005). SVMPs are
classiﬁed within four different groups, depending on their
domain composition. Group P-I is comprised by enzymes
presenting only the metalloproteinase domain, where the
characteristic zinc-binding signature (HEXXHXXGXXH
followed by a Met-turn) is present (Bode et al., 1993; Fox
and Serrano, 2005). Group P-II includes enzymes contain-
ing the metalloproteinase domain and a disintegrin
domain. SVMPs belonging to group P-III comprise metal-
loproteinase, disintegrin-like (Dis-like) and cysteine-rich
(Cys-rich) domains in a single polypeptide chain, many of
them being glycosylated. Finally, P-IV SVMPs are hetero-
dimers, with one subunit corresponding to a P-III chain and
another being a C-type lectin-like domain. Some SVMPs
have been classiﬁed in a number of subgroups within this
general structural frame (Fox and Serrano, 2005).
In general, the most potent hemorrhagic toxins belong
to the P-III SVMPs, and there is strong evidence suggesting
that the additional Dis-like and Cys-rich domains
contribute to the high hemorrhagic activity by targeting the
enzymes to relevant locations in the microvasculature and,
perhaps, by affecting coagulation as well (see below).
SVMPs of the groups P-I and P-III have been isolated from
the venom of B. asper (Arago´n-Ortiz and Gubensek, 1987;
Borkow et al., 1993; Gutie´rrez et al., 1995a; Franceschi et al.,
2000; Lorı´a et al., 2003). The concentration of P-I SVMPs is
higher than that of P-III SVMPs in the venom of adult
specimens of B. asper, whereas venoms of neonates have
a predominance of P-III SVMPs (Alape-Giro´n et al., 2008).
3.2. Pathogenesis of hemorrhage induced by B. asper venom
and isolated SVMPs
Injection of B. asper venom or isolated SVMPs in
experimental animals results in rapid and prominent
hemorrhage. The Minimum Hemorrhagic Dose of B. asper
venom, i.e. the amount of venom that induces a hemor-
rhagic halo of 10 mm diameter in the skin of mice 2 h after
injection, is 1.5 mg for the venom of specimens collected in
the Paciﬁc versant of Costa Rica, and 2.5 mg for venom from
specimen of the Caribbean region of the country (Gutie´rrez
et al., 1985). Similar values have been described for venoms
from Honduras and Guatemala (Rojas et al., 1987; Saravia
et al., 2001). Hemorrhagic activity of B. asper venom and
isolated SVMPs is completely abrogated upon incubation of
venom with metalloproteinase inhibitors, indicating that
SVMPs are the only hemorrhagic components in this
venom (Borkow et al., 1997; Escalante et al., 2000; Ruca-
vado et al., 2000). These ﬁndings also evidence that met-
alloproteinase activity is an absolute requirement for
exerting hemorrhagic effect.
Intramuscular injection of crude B. asper venom or
puriﬁed hemorrhagic SVMPs BaH1 (a P-III enzyme) and
BaP1 (a P-I enzyme) results in rapid damage to microvessel
structure, especially capillary vessels (Moreira et al., 1992,1994; Gutie´rrez et al., 2006). Capillary endothelial cells
show the following structural alterations: reduction in cell
thickness and in the number of pinocytotic vesicles,
appearance of small blebs protruding from the cell to the
vascular lumen, mitochondrial swelling and loss of endo-
thelial cell integrity (Moreira et al., 1992, 1994; Gutie´rrez
et al., 2006). In addition, the basement membrane (BM)
that surrounds the capillaries loses its continuity and is
absent in some locations (Moreira et al., 1992, 1994).
Distention of endothelial cells is associated with the
disruption in cell integrity leading to extravasation through
focal lesions (Fig. 1).
These observations are highly similar to those per-
formed with other hemorrhagic SVMPs from viperid
venoms (Ownby et al., 1978; Ownby and Geren, 1987;
Anderson and Ownby, 1997; Escalante et al., 2003). Similar
ultrastructural alterations were also observed in intravital
microscopy when B. asper venom was applied to mouse
cremaster muscle (Lomonte et al., 1994a). Using this
methodology, which allows the analysis of the dynamics of
pathological events in vivo, it was evident that hemorrhage
occurred in discrete locations in the microvasculature, with
‘explosive’ hemorrhagic events occurring at various sites in
the capillary network, characterized by a rapid bursting of
blood out of the microvessels forming localized hemor-
rhagic foci in the tissue (Lomonte et al., 1994a; Rucavado
et al., 1995).
SVMPs, including enzymes from B. asper venom,
degrade extracellular matrix proteins in vitro (Ohsaka et al.,
1973; Ohsaka, 1979; Baramova et al., 1989, 1991; Rucavado
et al., 1995; Franceschi et al., 2000; Escalante et al., 2006)
(Fig.1). Since SVMPs hydrolyze components of the BM, such
as laminin, nidogen/entactin, and type IV collagen, it was
proposed that such degradation of BM proteins plays
a central role in the pathogenesis of hemorrhage (Ohsaka
et al., 1973; Ohsaka, 1979; Bjarnason and Fox, 1994).
However, one puzzling observation in these in vitro studies
was that BM protein hydrolysis occurred at relatively late
time intervals, whereas in vivo hemorrhage develops
within minutes of injection.
On the other hand, the action of SVMPs on endothelial
cells has been investigated in cell culture conditions. In
contrast to the rapid disruption of endothelial cells in vivo
after injection of hemorrhagic SVMPs, incubation of these
enzymes with endothelial cells in culture did not result in
rapid cytotoxicity. Instead, the most notorious effect upon
incubation with B. asper SVMPs BaH1 and BaP1 was the
detachment of cells from their substratum, without rapid
loss in viability (Lomonte et al., 1994b; Borkow et al., 1995;
Rucavado et al., 1995; Dı´az et al., 2005). Similar observa-
tions were performed with the P-III SVMP jararhagin, from
the venom of the South American species Bothrops jararaca
(Tanjoni et al., 2005). At later time intervals of incubation
with SVMPs, endothelial cells may undergo apoptosis.
However, even though it was previously suggested that the
mechanism could be anoikis, resultant from the detach-
ment of cells and the interruption in viability signals that
depend on the contact between the cells and the extra-
cellular matrix (Dı´az et al., 2005; Tanjoni et al., 2005), new
results indicate that this might not be the case (O. Brenes
et al., unpublished results). These new data, obtained using
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concentrations that induce a signiﬁcant decrease in cell
viability are not able to promote cell detachment from the
plates, indicating that no strict correlation exists between
both events and suggesting that other mechanisms of
cytotoxicity are probably being triggered. However,
regardless of such apoptotic outcome, observations with
crude B. asper venom and isolated hemorrhagic SVMPs in
cell culture conditions clearly show that the rapid and
drastic endothelial cell pathology occurring in vivo is not
reproduced in cell culture.
This apparently puzzling situation could be explained
by a hypothesis concerning the mechanism of action of
hemorrhagic SVMPs, which incorporates both biochemical
and biophysical events in the pathogenesis of microvessel
damage and extravasation. According to this hypothesis,
capillary damage leading to hemorrhage occurs by a two-
step mechanism. In the ﬁrst step, hemorrhagic SVMPs
hydrolyze proteins of the capillary BM, as has been docu-
mented for B. asper SVMPs in vitro (Rucavado et al., 1995;
Franceschi et al., 2000; Escalante et al., 2006) and, more
recently, in vivo (Escalante et al., 2006). Such hydrolysis is
likely to result in the mechanical weakening of BM struc-
ture. BM plays the role of a mechanical scaffold of capillary
structure, being largely responsible for the Young’s elastic
module of capillaries (Milnor, 1980), thus resisting the
hemodynamic forces that tend to distend the capillary wall.
As a consequence of this proteolysis-mediated weakening,
in the second step of this pathological event the biophysical
forces normally operating in the microvasculature, mainly
hydrostatic pressure and tangential shear stress, induce the
distention of the capillary wall, eventually resulting in the
disruption of endothelial cell integrity and the consequent
extravasation (Gutie´rrez et al., 2005).
The ultrastructural observation of a drop in the number
of pinocytotic vesicles can be interpreted in the light of this
hypothesis as an adaptive response of endothelial cells to
distention, thus mobilizing membrane from the vesicles to
the plasma membrane (Lee and Schmid-Scho¨nbein, 1995).
Eventually, however, the distention overcomes this adap-
tive mechanism and endothelial cells become disrupted. In
this scenario, endothelial cell pathology corresponds to
a mechanically-induced necrosis. Clearly, this phenomenon
is not reproduced in cell culture conditions because theFig. 1. Effect of the P-I SVMP BaP1 on capillary vessel integrity and on
basement membrane. (A) Electron micrograph of a capillary vessel from the
gastrocnemius muscle of a mouse injected with saline solution. Notice the
typical ultrastructure of endothelial cell and the presence of basement
membrane (arrow). 17,000. (B) Electron micrograph of a capillary vessel of
mouse gastrocnemius muscle 5 min after injection of BaP1. The endothelial
cell is distended and has a reduced thickness, being devoid of pinocytotic
vesicles. There is a rupture in the integrity of endothelial cell (arrow head)
and loss of structure of basement membrane (arrow). A neutrophil (N) and
an erythrocyte (E) are present in the capillary lumen. 10,000. (C) Hydro-
lysis of Matrigel proteins by BaP1. Matrigel was incubated with the enzyme
at a 1:50 (w:w) enzyme:substrate ratio for 1 h and 3 h at 37 C. A control of
Matrigel incubated with saline solution was included (Control). Mixtures
were separated by SDS-PAGE run under reducing conditions in 4–15%
polyacrylamide gradient gel. Laminin chains and nidogen are shown in the
Matrigel control. Molecular mass references are indicated at the right. (A)
and (B) reprinted from Microvascular Research, Vol. 71, Gutie´rrez et al.,
copyright 2008, with permission from Elsevier.
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culture experiments. Experimental support for this two-
step hypothesis came from experiments in which blood
ﬂow in muscle tissue was interrupted. In these circum-
stances, the injection of hemorrhagic SVMP BaP1 did not
induce endothelial cell damage, thus evidencing that
biophysical forces associated with blood ﬂow play a key
role in endothelial cell damage and the ensuing hemor-
rhage (Gutie´rrez et al., 2006).
A pending issue is the analysis of the cleavage sites of
hemorrhagic SVMPs in key substrates in BM and the
consequences of the various cleavage patterns on BM
stability. The observation that non-hemorrhagic SVMPs are
also able to hydrolyze BM proteins in vitro (Rucavado et al.,
1999) suggests that it is not the cleavage of BM per se, but
the particular pattern of such cleavage, what is relevant for
the pathogenesis of hemorrhage. Different cleavage pattern
by jararhagin and BaP1 was described for nidogen, with
potentially different effects on the mechanical integration
of nidogen and other BM components (Escalante et al.,
2006). A detailed account on the in vitro and in vivo BM
degradation patterns induced by SVMPs having different
hemorrhagic potencies is required for a more in-depth
understanding of the pathogenesis of hemorrhage.
Furthermore, the role played by the Dis-like and Cys-rich
domains in the action of P-III SVMPs is another important
issue. Clearly, these additional domains contribute to the
higher hemorrhagic potency of this group of enzymes, as
compared to P-I SVMPs (Fox and Serrano, 2005).
The most likely mechanism to explain this role is the
ability of sequences found in these domains to direct the
enzyme to speciﬁc targets in extracellular matrix or endo-
thelial cells, in such a way that the enzyme is positioned in
a location where the proteinase activity is exerted in the
most effective way to affect capillary integrity. Although
these studies have not been carried out with B. asper venom
SVMPs, observations performed with jararhagin clearly
suggest that sequences in these domains allow the binding
to relevant substrates, such as proteins having von Wille-
brand factor A domains like collagens XII and XIV, matrilins
1, 3 and 4 and von Willebrand factor (Serrano et al., 2005,
2006, 2007), and to collagens I and IV (Moura-da-Silva
et al., 2008). Moreover, P-III SVMPs are poorly inhibited by
a2-macroglobulin, whereas P-I SVMPs are readily inhibited
by this plasma macromolecule (Baramova et al., 1990;
Kamiguti et al., 1994; Escalante et al., 2003, 2004; Lorı´a
et al., 2003). Finally, the ability of P-III SVMPs, but not P-I
SVMPs, to inhibit collagen-induced platelet aggregation
(Kamiguti et al., 1996; Jia et al., 1997; Moura-da-Silva et al.,
1999; Estevao-Costa et al., 2000), may also contribute to
their higher hemorrhagic activity.
3.3. Does apoptosis play a role in SVMP-induced endothelial
cell damage in vivo?
As described above, incubation of endothelial cells with
SVMPs in culture results in apoptosis (Wu et al., 2001; You
et al., 2003; Dı´az et al., 2005; Tanjoni et al., 2005). In the
case of B. asper SVMP BaP1, human capillary endothelial cell
apoptosis was independent of two Bcl-2 family members,
Bcl-xL and Bax, whereas procaspase-8 disappeared,probably reﬂecting its activation by a death receptor. Thus,
BaP1 induces apoptosis by a mechanism dependent on
caspase 8 activation (Dı´az et al., 2005). On the basis of these
observations in cell culture, it has been assumed that
endothelial cell apoptosis also occurs in vivo as a conse-
quence of the action of SVMPs. However, recent observa-
tions performed with B. asper hemorrhagic SVMP BaP1
question this assumption. No apoptosis was observed in
endothelial cells in the dermis of mouse ear skin after
injection of BaP1, as determined by the lack of TUNEL-
positive cells in capillaries (Jime´nez et al., 2008). It is sug-
gested that capillary endothelial cells aremostly affected by
mechanically-induced necrosis, as discussed above. The
role of in vivo apoptosis in capillary endothelial and other
cells in tissues demands further attention, but caution
should be taken when extrapolating conclusions from in
vitro observations to the more complex in vivo scenario
where these toxins exert their action.
3.4. Are arteries and arterioles also affected?
A number of experimental pathological observations
with crude B. asper venom indicate that larger vessels,
especially arterioles and arteries, are affected. Angionec-
rosis and thrombosis were described, together with loss of
immunostaining for endothelial cell markers in these
vessels (Tu and Homma, 1970; Arce et al., 1991). The
occurrence of angionecrosis in these experimental models
is a relevant ﬁnding that deserves further consideration,
owing to the implications that such pathology would have
in the overall context of local tissue damage. The toxins
involved and themechanisms behind these effects have not
been investigated, although it is tempting to suggest that
SVMPs andmyotoxic PLA2s are likely candidates. The ability
of a B. asper myotoxic PLA2 homologue to induce cytotox-
icity on arterial smooth muscle cells in culture has been
demonstrated (Mora et al., 2008). In addition, the presence
of thrombi in arterioles and arteries (Tu and Homma, 1969;
Homma and Tu, 1971; Arce et al., 1991) may also contribute
to vascular alterations leading to a deﬁcient perfusion to
distal muscle tissue.
4. Skin pathology induced by B. asper venom:
blistering and dermonecrosis
Intramuscular or subcutaneous injection of the venom
of B. asper, and other viperid and some elapid venoms, in
human victims results in acute damage to the skin,
provoking hemorrhage, dermonecrosis and blistering
(Gutie´rrez, 1995; Otero et al., 2002; Warrell, 2004). Such
effects have been reproduced in experimental models,
which have allowed the study of the mechanisms involved
and the toxins responsible. A laboratory test was developed
by Theakston and Reid (1983) in which rodents receive an
intradermal injection of a venom or toxin, and the area of
dermonecrosis is measured in the inner side of the skin
72 h after injection. The activity of venoms is expressed as
the Minimum Necrotizing Dose, deﬁned as the dose of
venom that induces a necrotic area of 5 mm diameter
(Theakston and Reid, 1983). This assay assesses the ability
of venoms to induce dermonecrosis. Using this test, it was
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B. asper was completely abrogated by SVMP inhibitors,
thus evidencing that in this venom SVMPs are the main
components responsible for the effect (Rucavado et al.,
2000).
Two investigations have addressed the mechanism of
skin damage by B. asper SVMP BaP1 using intramuscular
and intradermal routes of injection (Rucavado et al., 1998;
Jime´nez et al., 2008). In the dermis, BaP1 induced
a hemorrhagic effect of rapid onset, associated with loss of
immunostaining for capillary endothelial cell markers and
BM components. Simultaneously, a marked edema devel-
oped in the dermis. Blisters also formed within the ﬁrst
hours of injection, with a clear separation of dermis and
epidermis and with the accumulation of a proteinaceous
exudate (Fig. 2). No apparent histological damage was
observed in epithelial cells of epidermis, although TUNEL
staining revealed widespread apoptosis in these cells at 6 h
(Jime´nez et al., 2008). Immunostaining of BM components
revealed that laminin and type IV collagen mostly
remained at the base of the blister, with little or no staining
in the roof of the blister (Jime´nez et al., 2008). This obser-
vation strongly suggests that blisters are formed predom-
inantly by the proteolytic cleavage of components of theFig. 2. Hemorrhage, blistering and myonecrosis induced by B. asper SVMP
BaP1. (A) Light micrograph of a section of mouse ear injected intradermally
with BaP1. Abundant hemorrhage is observed in the dermis (arrow). A
blister is observed (*) with a clear separation of epidermis from the dermis.
200. (B) Light micrograph of a section of gastrocnemius muscle 6 h after
injection of BaP1. Scattered necrotic muscle ﬁbers are observed (arrows),
together with an inﬂammatory inﬁltrate. 200.dermal–epidermal interface at the region of lamina lucida,
with the consequent separation of epidermis from dermis
and with components of the lamina densa and the
anchoring ﬁbrils remaining attached to the dermis. In
agreement, extravasated erythrocytes are not released
from the dermis to the blister ﬂuid.
This proteolytic cleavagemay be due to the direct action
of the SVMP or, alternatively, to the action of endogenous
proteinases synthesized and released in the tissue as
a consequence of the ensuing inﬂammatory reaction. An
increment in the expression of matrix metalloproteinase-9
(MMP-9) after injection of an SVMP was shown by
zymography on gelatin gels (Rucavado et al., 1998).
However, the large majority of MMP-9 and MMP-2 in the
tissue corresponded to the latent forms of these enzymes,
with very little activation, suggesting that MMPs are
regulated and remain mostly inactive by the time blisters
are developing, i.e. within the ﬁrst hours. In muscle tissue
injected with B. asper venom, activated variants of MMP-9
are observed at later time intervals (Saravia-Otten et al.,
2004) and, therefore, these are not likely to be involved in
the ﬁrst stages of acute damage. Neutrophil and other
endogenous proteinases are associated with the patho-
genesis of some blistering disorders (Ray et al., 2002;
Greenberg et al., 2006). However, in the case of BaP1-
induced skin pathology, elimination of neutrophils, by
pretreatment with an anti-granulocyte monoclonal anti-
body, did not affect the main pathological outcomes after
toxin injection, i.e. hemorrhage and blistering (Jime´nez
et al., 2008). Taken together, these observations strongly
suggest that skin hemorrhage and blistering induced by
BaP1 depend on the direct proteolytic cleavage of capillary
BM and dermal–epidermal junction components.
Blistering is followed, in many regions of the affected
skin, by loss of epidermis and ulceration, with the forma-
tion of an eschar (Rucavado et al., 1998; Jime´nez et al.,
2008). A process of re-epithelialization ensues afterwards,
with replication of epithelial cells at the borders of the
eschar, and migration over the denuded skin. In this
experimental model, after a period of two to four weeks,
the epidermis shows a complete regeneration, with the
presence of skin appendages and the absence of scar tissue
and ﬁbrosis (Rucavado et al., 1998; Jime´nez et al., 2008). In
parallel, the drastic reduction in the microvascular density
in the dermis, as a result of the direct damage induced by
BaP1 in capillary vessels, is followed by rapid angiogenesis
and revascularization, with microvascular density reaching
values approaching those of control tissue preparations
(Jime´nez et al., 2008).
5. Extracellular matrix degradation
Extracellular matrix constitutes a highly complex and
multifunctional structure that plays a relevant role in many
aspects of tissue homeostasis, such as establishment of
tissue architecture and cellular spatial organization, cell
migration in tissue differentiation, participation in orderly
cell replacement after tissue repair or regeneration, provi-
sion of storage sites for a number of growth factors and
other intercellular mediators, presence of cryptic molecular
regions that release a plethora of molecules for the
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extracellular volume and composition, among other roles
(Kalluri, 2003). Therefore, the injection of venom hydro-
lases in the tissues after snakebite, with the consequent
hydrolysis of extracellular matrix components, constitutes
a highly relevant aspect of venom-induced local pathology.
The effects of SVMPs on a specialized type of extracellular
matrix, i.e. the BM, were discussed above in relation to the
pathogenesis of hemorrhage and blistering. However,
a more general degradation of extracellular matrix is likely
to occur in these envenomations as well. In the case of
B. asper venom, SVMPs, serine proteinases and hyaluroni-
dases, among other components, are candidates for playing
a relevant role in extracellular matrix damage. Unfortu-
nately, with the exception of the discussed effects of
hemorrhagic and non-hemorrhagic SVMPs on various BM
components and ﬁbronectin, mostly by in vitro studies, this
aspect of local pathology has received little attention from
an in vivo experimental standpoint.
The hydrolysis of hyaluronic acid by hyaluronidase,
which has been shown to occur in vitro by B. asper venom
(Gene´ et al., 1985), is likely to play a role as a spreading
factor, as demonstrated by the increment in local hemor-
rhagic activity of a SVMP when injected with a puriﬁed
hyaluronidase (Tu and Hendon, 1983). Accordingly, it has
been proposed that the inhibition of hyaluronidase, by
synthetic inhibitors such as cromoglycate and aurothio-
malate, reduces the extent of local tissue damage induced
by several snake venoms (Yingprasertchai et al., 2003). In
addition, extracellular matrix degradation by SVMPs may
contribute to the local and systemic diffusion of venom
components (Anai et al., 2002). On the other hand, in
addition to the direct action of venom hydrolases on
extracellular matrix components, the inﬂammatory
response of tissues to venom injection involves the
expression of endogenous proteinases, especially MMPs
(Rucavado et al., 1998; Saravia-Otten et al., 2004). However,
the increments in MMP-9 correspond to the latent form of
this enzyme during the acute inﬂammatory reaction after
injection of the SVMP BaP1 (Rucavado et al., 1998). The
active form of MMP-9 is observed only at later time inter-
vals after injection of crude B. asper venom (Saravia-Otten
et al., 2004). Experiments performed with B. asper venom
and ﬁbroblast cell cultures also evidenced that MMPs
synthesized by these cells, upon incubation with B. asper
venom, are activated by the action of a serine proteinase
(Saravia-Otten et al., 2004). Nevertheless, injection of
a puriﬁed serine proteinase from the venom of B. asper did
not induce any evidence of local pathology in mice, nor did
it activate proMMP-2 or -9 (Pe´rez et al., 2007), thus
suggesting that venom serine proteinases probably play
a veryminor role in the pathogenesis of local tissue damage
in these envenomations. It is therefore likely that SVMPs,
and perhaps hyaluronidase, are the components that play
the predominant role in the degradation of extracellular
matrix in envenomations by B. asper. Consequently, the in
situ inhibition of SVMPs, by the local injection of metal-
loproteinase inhibitors, represents a potentially useful
therapeutic approach to prevent various aspects of venom-
induced local tissue damage, such as hemorrhage,
myonecrosis secondary to microvessel damage, blistering,dermonecrosis, and extracellular matrix degradation
(Escalante et al., 2000; Rucavado et al., 2000; Gutie´rrez
et al., 2007).
6. Local myonecrosis
6.1. PLA2s and PLA2 homologues are the main myotoxic
components in B. asper venom
The venom of B. asper induces prominent local myo-
necrosis in experimental animals (Gutie´rrez et al., 1980a,
1984b; Arce et al., 1991), in agreement with clinical
observations (Otero et al., 2002; Warrell, 2004). This local
myonecrosis is predominantly caused by a group of basic
components which include PLA2s and PLA2 homologues
(Gutie´rrez and Lomonte, 1995, 1997). They are myotoxins I
and III, which are catalytically-active Asp49 PLA2s (Gutie´r-
rez et al., 1984a; Kaiser et al., 1990), andmyotoxins II and IV,
which are catalytically-inactive PLA2 homologues that
present critical substitutions at position 49 and at residues
forming the calcium-binding loop (Lomonte and Gutie´rrez,
1989; Francis et al., 1991; Dı´az et al., 1995; Lizano et al.,
2001). The complete amino acid sequence of several of
these myotoxic components has been determined (Kaiser
et al., 1990; Francis et al., 1991; Lizano et al., 2001) and the
crystal structure of myotoxin II, a Lys49 homologue, has
been described (Arni et al., 1995). The lack of enzymatic
activity in the Lys49 PLA2 homologues derives from the
inability of these variants to bind the calcium ion required
for catalysis, owing to the substitutions occurring at residue
49 and at various residues of the calcium-binding loop
(Francis et al., 1991; Arni et al., 1995; Lomonte et al., 2003a).
Overall, this group of basic myotoxic components
comprisesw15–35% of the total proteins in B. asper venom
(Gutie´rrez and Lomonte, 1995; Alape-Giro´n et al., 2008).
6.2. Basic myotoxic components affect the integrity of the
plasma membrane of skeletal muscle ﬁbers
Intramuscular injection of crude B. asper venom or these
basic PLA2s and PLA2 homologues results in rapid myo-
necrosis, revealed by histological alterations and by an
increment in the plasma activity of muscle-derived
enzymes, such as creatine kinase (CK) (Gutie´rrez et al.,
1980a, 1984a; Lomonte and Gutie´rrez, 1989). A cytotoxic
activity also occurs inmyoblasts and especially inmyotubes
in culture (Lomonte et al., 1999; Angulo and Lomonte,
2005) and in isolated muscle preparations in vitro
(Gutie´rrez et al., 1986a; Bultro´n et al., 1993a), in agreement
with observations carried out with other Bothrops sp.
venoms and myotoxins (Melo and Sua´rez-Kurtz, 1988;
Rodrigues-Simioni et al., 1995).
The following experimental observations strongly
indicate that the initial attack of B. asper myotoxins on
muscle ﬁbers occurs at the plasma membrane, with a rapid
and drastic perturbation in the integrity of sarcolemma:
(a) At the ultrastructural level, there are abundant inter-
ruptions in the integrity of plasma membrane (Gutie´rrez
et al., 1984b) (Fig. 3). (b) The earliest histopathological
alteration in vivo corresponds to focal lesions at the
periphery of muscle ﬁbers, known as ‘delta lesions’
Fig. 3. Acute pathological effects induced by B. asper myotoxic Asp49 phospholipase A2 (myotoxin I) in mouse skeletal muscle. (A) Light micrograph of muscle
tissue 30 min after toxin injection. Focal lesions (‘delta lesions’) are observed at the periphery of muscle ﬁbers (arrows). 350. (B) Electron micrograph of
a peripheral portion of a muscle ﬁber 30 min after injection of myotoxin. The integrity of plasma membrane has been lost, and only the basal lamina remains (BL).
There is a group of degenerated mitochondria (Mi) with disruption of their membranes (arrowheads). A portion of hypercontracted myoﬁlaments is observed.
24,000. Reprinted from Experimental and Molecular Pathology, Vol. 40, Gutie´rrez et al., copyright 1984, with permission from Elsevier.
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correspond to peripheral areas of cell degeneration that
develop secondarily to plasma membrane damage (Mokri
and Engel, 1975). (c) A rapid increment in cytosolic calcium
occurs in myotubes in culture (Villalobos et al., 2007) and
in muscle cells in vivo (Gutie´rrez et al., 1984a), probably as
a consequence of plasma membrane disruption, and loss in
the control of calcium permeability. The ability of these
myotoxins to affect the integrity of cell membranes has
also been described in a variety of cell types in culture, as
evidenced by a rapid release of cytosolic markers, such as
lactic dehydrogenase (Lomonte et al., 1994c, 1999), and the
incorporation of extracellular markers (Bultro´n et al.,
1993b; Villalobos et al., 2007; Mora et al., 2008). Moreover,
B. asper myotoxins are capable of disrupting the integrity
of liposomes by catalytically-dependent and independent
mechanisms (Dı´az et al., 1991, 2001; Ruﬁni et al., 1992).
The mechanisms by which B. asper myotoxins disrupt
the integrity of muscle cell plasma membrane remain
unknown in their details. However, it is clear that catalyt-
ically-dependent and independent events are involved.
Regarding enzymatically-inactive Lys49 PLA2 homologues,
it is evident that membrane disruption occurs without
phospholipid hydrolysis. In the case of B. aspermyotoxin II,
a stretch of cationic and hydrophobic residues, located at
the C-terminus of the molecule, plays a key role in
membrane perturbation (Lomonte et al., 1994d, 2003a;
Caldero´n and Lomonte, 1998). A similar mechanism has
been advocated for a number of additional Lys49 PLA2s
from other Bothrops sp. venoms (Lomonte et al., 2003a,b;
Chioato et al., 2002; Chioato andWard, 2003). Interestingly,
this region also plays a determinant role in other biological
activities displayed by myotoxin II, such as hyperalgesia
(Chacur et al., 2003) and bactericidal activity (Pa´ramo et al.,
1998).
A structural feature characteristic of local myotoxic
PLA2s is a cationic face which is likely to interact with
negatively-charged phospholipid bilayers (Falconi et al.,
2000; Murakami and Arni, 2003; Gutie´rrez et al., 2008).This initial electrostatic interaction is probably followed by
the penetration and disorganization of the membrane by
the C-terminal region (Lomonte et al., 2003a). Additional
structural features might also contribute to the membrane-
perturbing activity (Dı´az et al., 1994). The dimeric character
of many of these myotoxins would enable a shift in
quaternary structure that facilitates membrane penetration
(da Silva-Giotto et al., 1998). More recently, the observation
of a fatty acid moiety within the structure of Lys49 PLA2
homologues (de Azevedo et al., 1999; Ambrosio et al., 2005)
has been proposed to induce the exposure of a knuckle
constituted by hydrophobic residues, contributing to the
ability of these proteins to disturb the bilayer (Ambrosio
et al., 2005).
In the case of B. asper myotoxins I and III, which are
Asp49 catalytically-active PLA2s, phospholipid hydrolysis
plays a critical role in muscle ﬁber plasma membrane
destabilization, as revealed by a prominent drop in myo-
toxicity in conditions that inhibit phospholipase A2 activity
(Bultro´n et al., 1993b; Dı´az-Oreiro and Gutie´rrez, 1997). The
role played by enzymatic phospholipid hydrolysis may be
associated with the perturbation of membrane integrity,
secondary to hydrolysis, or to the effect exerted by the
products of phospholipid degradation, i.e. lysophospholi-
pids and fatty acids (Montecucco et al., 2008). Lysolecithin
has been shown to induce sarcolemmal disruption and
myonecrosis (Pestronk et al., 1982) and to affect the func-
tion of membranes in a number of ways (Montecucco et al.,
2008). In addition, B. asper myotoxic Asp49 PLA2s are still
capable of inducing myotoxicity even in conditions that
abrogate phospholipase activity (Gutie´rrez et al., 1986a;
Bultro´n et al., 1993b), thus suggesting that molecular
regions distinct from the catalytic site are able to interact
and disrupt the integrity of muscle ﬁber plasmamembrane.
The identity of these molecular regions remains largely
unknown, although it is likely that they may comprise
hydrophobic-cationic stretches similar to the ones present
in the C-terminus of Lys49 PLA2 homologues. Observations
with myotoxic Asp49 PLA2s agree with the general
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the pharmacological proﬁle of venom PLA2s, i.e. that these
enzymes have molecular regions that determine their
toxicity and tissue speciﬁcity in addition to the catalytic
activity.
6.3. Are B. asper myotoxins ‘speciﬁc’ for muscle cells?
When the ﬁrst myotoxic PLA2 from the venom of B. asper
was isolated (Gutie´rrez et al., 1984a) it was named ‘B. asper
myotoxin’, implicitly assuming that the main toxic activity
of this enzyme is cytotoxicity on muscle ﬁbers. However,
further studies evidenced that this, and other basic PLA2s
and PLA2 homologues present in this venom, exerted
awider cytotoxic proﬁle, affecting many different cell types
(Bultro´n et al., 1993b; Lomonte et al., 1994c), although
mature muscle cells and myotubes showed the highest
susceptibility to these toxins (Lomonte et al., 1999; Angulo
and Lomonte, 2005). The widespread cytotoxic proﬁle of
these molecules has been ascribed to their ability to
interact with low-afﬁnity sites, probably phospholipids, in
the plasma membrane of a variety of cell types. This
property is likely to depend on the presence of a cationic
face in these toxins which enables them to interact with
negatively-charged phospholipids in membranes (Falconi
et al., 2000; Murakami and Arni, 2003; Gutie´rrez et al.,
2008). The role of negatively-charged phospholipids as
low-afﬁnity ‘acceptors’ of B. asper myotoxins is supported
by the higher susceptibility to these toxins of liposomes
made of negatively-charged phospholipids (Dı´az et al.,
1991, 2001; Ruﬁni et al., 1992), and by the observation that
erythrocytes are rendered susceptible to the lytic activity of
these toxins by the addition of phosphatydilserine to their
membrane, thus increasing the density of negatively-
charged phospholipids (Dı´az et al., 2001).
On the other hand, the high susceptibility of muscle
ﬁbers to these toxins may be a consequence of the presence
of ‘acceptors’ of higher afﬁnity, perhaps of protein nature, in
the muscle ﬁber membrane. The identity of these ‘accep-
tors’ remains largely unknown. The M-typePLA2 receptor
identiﬁed in rabbit skeletal muscle (Lambeau et al., 1990)
does not seem to play a relevant role in myotoxicity
induced by B. asper myotoxin II (G. Lambeau, personal
communication). Recently, a high afﬁnity binding has been
described between Lys49 PLA2 homologues, including
B. aspermyotoxin II, and vascular endothelial growth factor
receptor-2 (VEGFR-2) (Fujisawa et al., 2008), although the
functional implications of such ﬁnding are not clear at
present.
Myotoxic PLA2s and PLA2 homologues present in
B. asper and other Bothrops sp. venoms are mostly ‘locally-
acting myotoxins’, in the sense that their intramuscular
injection results in necrosis in muscles located in the
vicinity of the injection site, with little action on distant
ones (Gutie´rrez and Ownby, 2003; Gutie´rrez et al., 2008).
In addition, intravenous injection of these myotoxins
results in very little increment in plasma CK activity
(Moreno and Gutie´rrez, 1988; Gutie´rrez et al., 2008).
A toxicokinetic analysis conﬁrmed the local concentration
of B. asper myotoxin I at the injected muscle (Moreno and
Gutie´rrez, 1988). This situation contrasts with what hasbeen described for other myotoxic PLA2s, such as crotoxin,
from the venom of the South American rattlesnake
Crotalus durissus terriﬁcus (Kouyoumdjian et al., 1986;
Salvini et al., 2001), and a number of class I myotoxic
PLA2s isolated from elapid venoms (Fohlman and Eaker,
1977; Ponraj and Gopalakrishnakone, 1996). These PLA2s
induce both local and systemic myotoxicity, owing to the
higher selectivity of these toxins for muscle ﬁbers and to
their ability to act on muscles distant from the site of
injection. These ‘systemically-acting myotoxins’ provoke
rhabdomyolysis and prominent increments in plasma CK
activity and in myoglobin, resulting in myoglobinuria
(Ponraj and Gopalakrishnakone, 1996). This dichotomy
between local and systemic myotoxicity has a well-
deﬁned clinical correlate, since envenomations by B. asper,
and other Bothrops species, results in prominent local
myonecrosis, but no systemic myotoxicity (Otero et al.,
2002; Gutie´rrez, 1995; Warrell, 2004). In contrast, enve-
nomations by C. d. terriﬁcus and several elapid snakes
result in rhabdomyolysis and acute renal failure (Azevedo-
Marques et al., 1987; Warrell, 1996). Such drastically
different toxicologic and clinical proﬁles seem to depend
on how speciﬁc these types of myotoxic PLA2s and PLA2
homologues are for muscle ﬁber membranes.
6.4. Plasma membrane perturbation is followed by
a prominent calcium inﬂux and a stereotyped sequence of
cellular pathological effects
The rapid and drastic plasma membrane perturbation
induced by B. asper myotoxic PLA2s and PLA2 homologues
promotes an inﬂux of calcium from the extracellular ﬂuid to
the cytosol, rapidly elevating the cytosolic concentration of
this cation (Gutie´rrez et al., 1984a; Villalobos et al., 2007;
Montecucco et al., 2008). Such calcium inﬂux triggers
a number of deleterious cellular processes that rapidly
bring the cell beyond the ‘point of no return’. The most
important consequences of such calcium increment are: (a)
hypercontraction of myoﬁlaments, resulting in the forma-
tion of amorphous masses of myoﬁbrils and cytoplasmic
spaces devoid of myoﬁlaments (Gutie´rrez et al., 1984b). In
addition to impairing the mechanical integration of the
contractile apparatus, such drastic hypercontraction
induces further mechanical disruption of the integrity of
the plasma membrane, thus promoting a vicious circle that
results in more calcium entering the cell. (b) Mitochondria
begin to transport excess calcium, through the action of the
uniporter and using the proton gradient that exists across
the inner mitochondrial membrane. This affects the
synthesis of ATP and results in the accumulation of large
amounts of calcium in the mitochondrial matrix, with the
formation of hydroxyapatite crystals (Gopalakrishnakone
et al., 1984). As a consequence, mitochondria become
swollen and ﬂocculent densities appear in their matrix;
furthermore, mitochondrial membranes appear inter-
rupted. It is likely that these alterations also result in the
formation of the ‘permeability transition pore’, with the
release of ‘death factors’ from mitochondria (Dong et al.,
2006; Montecucco et al., 2008). In the end, mitochondria
become irreversibly damaged and ATP synthesis is severely
hampered. (c) Activation of calcium-dependent proteinases
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dependent cysteine proteinases, become activated and
hydrolyze a series of cellular substrates, particularly
cytoskeletal components responsible for the mechanical
integration of myoﬁbrillar proteins (Dargelos et al., 2008).
Early loss of immunostaining of desmin and a-actinin was
described in muscle injected with a myotoxic PLA2 from
B. asper venom (Gutie´rrez et al., 1990). On the other hand,
increments in cytosolic calciummay result in the activation
of calcium-dependent cytosolic PLA2s, whichwould further
degrade phospholipids from plasma membrane and the
membranes of intracellular organelles, such as mitochon-
dria, sarcoplasmic reticulum and T tubules (Montecucco
et al., 2008).6.5. What is the role of ischemia in myonecrosis induced by
B. asper venom?
Incubation of B. asper venomwith polyclonal antibodies
against a myotoxic PLA2 reduces the myotoxic activity of
this venom by approximately 70%, conﬁrming the protag-
onic role played by these molecules in myonecrosis
(Lomonte et al., 1987). However, the fact that there is still
30% of muscle damage in these conditions reveals that
other venom components also contribute to acute muscle
damage. Experimental observations demonstrate that
hemorrhagic SVMPs, such as B. asper enzymes BaH1 and
BaP1, induce myonecrosis as well (Gutie´rrez et al., 1995b;
Rucavado et al., 1995) (Fig. 2). The mechanism by which
hemorrhagic SVMPs cause myonecrosis has not been ﬁrmly
established, although a very plausible hypothesis is that
they promote muscle damage secondary to the ischemia
resultant from the action of these SVMPs on the micro-
vasculature (Gutie´rrez et al., 1995b).
The increment demonstrated in the levels of lactic acid
in muscle injected with BaH1, and the lack of in vitro
myotoxicity of this enzyme in muscle preparations in
conditions where oxygen is supplied support this hypoth-
esis (Gutie´rrez et al., 1995b). Thus, the interruption of blood
ﬂow and perfusion in a tissue in which the microvascula-
ture has been severely hampered by the action of SVMPs is
a mechanism that contributes to local myonecrosis. In
addition, other vascular alterations, such as angionecrosis
and thrombosis, may further impair tissue perfusion.
Finally, the increment in muscle intracompartmental
pressure, as a consequence of the prominent extravasation
associated with edema, inﬂammation and bleeding, might
be another contributing factor to ischemia. There have been
no experimental studies on the role of increments in
intracompartmental pressures in myonecrosis in the case
of B. asper envenomations. However, a study performed in
pigs with the venom of Crotalus atrox demonstrated that
surgical decompression reduces the increment in intra-
compartmental pressure, but increases the extent of myo-
necrosis (Tanen et al., 2004), thus suggesting that, at least
in this model, muscle necrosis is more the result of the
direct toxic activity of venom components than the indirect
effect of compression-induced ischemia. Owing to its
evident clinical implications, this is a subject that requires
further experimental analysis.7. Ontogenetic variations in venom and implications
in local tissue damage
Pronounced differences have been described between
the venoms of newborn/neonate specimens and those of
adult specimens of B. asper from Costa Rica and Colombia
(Gutie´rrez et al., 1980b; Chaves et al., 1992; Saldarriaga
et al., 2003; Alape-Giro´n et al., 2008). Regarding local
effects, the venoms of newborn specimens induce stronger
hemorrhagic and edema-forming activities than those of
adults, whereas the latter induce stronger myonecrosis
(Gutie´rrez et al., 1980b; Saldarriaga et al., 2003). Such
different pathophysiological proﬁles can be understood in
the light of the proteomes of these venoms, since those
from newborns have a large content of P-III SVMPs and
a very low content of myotoxic basic PLA2s and PLA2
homologues. In contrast, venoms from adults present
a relatively low content of P-III SVMPs, and a high amount
of myotoxic PLA2s (Lomonte and Carmona, 1992; Alape-
Giro´n et al., 2008). Thus, venoms from newborn B. asper
have a predominantly ‘vasculotoxic’ proﬁle, whereas those
from adults present a predominantly ‘myotoxic’ proﬁle. The
clinical implications of these ﬁndings, however, have to be
analyzed with caution, since the volume of venom deliv-
ered by newborn and adult specimens is very different.
8. Does inﬂammation contribute to local pathology?
Injection of B. asper venom, and viperid venoms in
general, results in a complex and multifactorial inﬂamma-
tory reaction (Farsky et al., 2005). The description and
mechanisms of inﬂammatory events induced by B. asper
venom are covered in detail in another contribution of this
issue (see Teixeira et al., this issue) and, therefore, are
beyond the scope of this review. However, the possible
pathological consequences of such inﬂammatory reaction
need to be considered herein. Owing to the extent of such
reaction, and to the well-known pathological role that
some inﬂammatory pathways and mediators play in tissue
damage in many diseases (Gallin and Snyderman, 1999), it
has been often assumed that local inﬂammation contrib-
utes to the local pathological effects in viperid snakebite
envenomation. A number of studies have addressed this
issue in the case of B. asper venom by an experimental
approach in which speciﬁc inﬂammatory cells and media-
tors have been depleted or blocked, and the effects of these
interventions in the extent of local pathology have been
assessed.
8.1. Role of neutrophils
As part of a typical inﬂammatory reaction after injection
of B. asper venom or myotoxins, neutrophils accumulate in
the affected tissues within the ﬁrst hours of venom injec-
tion, with a peak at 24 h, in the case of acute muscle
damage (Gutie´rrez et al., 1986b, 1990; Teixeira et al.,
2003b). Elimination of neutrophils in a mouse model, by
administration of a monoclonal rat antibody against mouse
granulocytes, has been used to assess the role of these cells
in the local pathology induced by B. asper venom and
amyotoxin (Teixeira et al., 2003b). Results clearly show that
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neutrophil-depleted animals did not differ from the extent
of damage in mice having neutrophils, strongly suggesting
that these cells do not participate in the pathogenesis of
tissue damage, at least in this model. The only difference
observed between these groups of mice occurred in
skeletal muscle regeneration, since neutropenic mice
presented a deﬁcient and delayed regenerative response, as
compared to control mice (Teixeira et al., 2003b). This
evidences that neutrophils play a relevant role in muscle
regeneration, probably by removing necrotic debris and
providing mediators that stimulate macrophage recruit-
ment and other aspects of the regenerative response.
8.2. Role of cytokines
Injection of B. asper venom, myotoxins or hemorrhagic
toxins results in the increments of several cytokines in the
affected tissue and in blood (Lomonte et al., 1993; Rucavado
et al., 2002; Petricevich et al., 2000; Chaves et al., 2005).
The highest increments in muscle tissue were described for
IL-6 and IL-1b, whereas TNF-a did not show elevations
(Rucavado et al., 2002). When a dose of B. asper venom
corresponding to one LD50 was injected by the intraperi-
toneal route, there were increments in the serum levels of
TNF-a, IL-1b, IL-6, IL-10 and IFN-g (Petricevich et al., 2000).
Studies with the SVMP jararhagin suggest that TNF-a and
IL-6, but not IL-1b, play a role in the local dermonecrotic
effect induced by this toxin (Moura-da-Silva et al., 1996;
Laing et al., 2003). However, pretreatment of mice with
pentoxifylline, an inhibitor of the transcription of TNF-a, or
with antibodies against TNF-a, IL-1b or IL-6 did not modify
the extent of local edema, hemorrhage, dermonecrosis or
myonecrosis induced by B. asper venom in mice (Chaves
et al., 2005), thus not supporting a role for these cytokines
in the pathogenesis of the acute local tissue damage
induced by this venom. However, it is necessary to assess
the role of cytokines in other aspects of local pathology in
B. asper envenomation.
8.3. Role of nitric oxide
Local and systemic increments in nitric oxide (NO) have
been documented after injection of B. asper venom in mice
(Petricevich et al., 2000; Chaves et al., 2006). Inhibition of
NO synthase by pretreatment of mice with L-NAME and
aminoguanidine did not reduce the extent of local hemor-
rhage and myonecrosis induced by B. asper venom, but
reduced the extent of local edema, albeit to a limited extent
(Chaves et al., 2006). Thus, this mediator does not partici-
pate in the local pathological effects, but contributes to the
pharmacological processes that lead to edema, together
with other inﬂammatory mediators.
Taken together, the experimental assessment of the role
played by neutrophils, cytokines and NO in the local tissue
damage induced by B. asper venom strongly suggests that
these inﬂammatory cells and mediators do not contribute
to a signiﬁcant extent in the pathogenesis of acute local
hemorrhage and myonecrosis in our animal models. The
scenario that emerges from these observations is one in
which the local pathology is mostly caused by the directaction of venom PLA2s and SVMPs in the tissue. The
prominent inﬂammatory reaction that ensues is likely to
participate in the processes of tissue repair and regenera-
tion. Therefore, the manipulation of the local inﬂammatory
response has to be analyzed in the light of this hypothesis,
in order to promote its favorable aspects that contribute to
tissue regeneration (Gutie´rrez et al., 2007). Clearly, more
research is required in other aspects of local inﬂammation
and in the development of additional experimental models,
in order to obtain a more complete view of the role of
inﬂammation in B. asper venom-induced local pathology.
For instance, the assessment of the role played by macro-
phages and mast cells is pending, as well as the possible
involvement of complement in these alterations.
9. The interplay between local pathology and local
infection in B. asper envenomation
Local infection occurs in a percentage of patients
envenomated by B. asper and other viperid species (Otero
et al., 1992, 2002; Jorge et al., 1994; Avila-Agu¨ero et al.,
2001), and local abscess formation is a risk factor for
amputation in human snakebite victims (Saborı´o et al.,
1998; Jorge et al., 1999). Bacteria isolated from local
abscesses in these patients include species present in the
mouth and venom of the snakes (Arroyo and Bolan˜os,
1980; Jorge et al., 1994), as well as in the skin of the
victims, such as Staphylococcus aureus (Avila-Agu¨ero et al.,
2001; Otero et al., 2002). Such local infection, which leads
to cellulitis, local abscesses and, in some cases, sepsis,
demands the use of antibiotics as a frequent therapeutic
intervention in the management of these envenomations
(França and Ma´laque, 2003; Gutie´rrez, 1995). The role of
venom-induced local pathology in promoting local infec-
tion by S. aureus was investigated in a mouse model.
Results clearly showed that local tissue damage induced by
either B. asper venom, a myotoxin or a hemorrhagic SVMP
strongly favors staphylococcal infection (Saravia-Otten
et al., 2007). It was proposed that the binding of bacteria to
soluble tissue factors released as a result of the action of
venom components may hamper the recognition of
bacteria by the immune mechanisms. Moreover, the
degradation of innate immune host factors by venom
proteinases may also contribute to the infection (Saravia-
Otten et al., 2007). Thus, there is an evident interplay
between local pathological alterations induced by venom
toxins and local infection by bacteria: tissue damage
clearly favors local infection and, in turn, local infection
further enhances local pathology in these envenomations.
10. Towards an integrative scenario: multiple
interacting pathological events and multiple tissue
responses mediate a complex outcome
The injection of a viperid snake venom, such as that of
B. asper, in muscle tissue results in a multiplicity of cellular
and tissue reactions, some of which are the consequence of
the direct action of venom components whereas others
depend on the tissue responses that follow venom-induced
damage. An additional observation is that venom PLA2s and
SVMPs, which promote cell and tissue damages, may also
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a Lys49 PLA2 homologue from B. asper venom induces
cellular responses as varied as necrosis, apoptosis and
proliferation in a lymphoblastoid cell line in culture,
depending on the concentration of the toxin (Mora et al.,
2005), and these diverse effects are associatedwith variable
levels of cytosolic calcium increments (Mora et al., 2006).
The ability of B. asper myotoxins to activate macrophages,
when tested at sub-cytotoxic concentrations, has been also
documented (Zuliani et al., 2005), as well as the increment
in the expression of a number of genes in ﬁbroblasts incu-
bated with sub-cytotoxic concentrations of B. asper SVMP
BaP1 (unpublished results), similarly to what has been
described for the action of jararhagin and B. jararaca venom
in ﬁbroblasts and endothelial cells (Gallagher et al., 2003,
2005). Moreover, P-III SVMPs from other Bothrops sp.
venoms activate endothelial cells (Schattner et al., 2005).
These observations suggest that different cell types may
have different thresholds for different cellular responses
when incubated with a particular toxin. Therefore,
depending on the concentration reached by a particular
toxin in a particular tissue location, and also depending on
the susceptibility/reactivity of a speciﬁc cell type to a given
toxin, cellular responses after injection of venom may vary
from overt necrosis, to apoptosis, to activation leading to
proliferation or synthesis of mediators of various sorts.
The simplistic view that injection of a viperid venom
into a tissue only results in widespread direct damage to
cellular and extracellular matrix components has to be
substituted by a more integrative scenario in which
different cells respond in different ways to different toxins.
In the tissue regions that may be considered ‘ground zero’,
i.e. where the maximum concentration of venom compo-
nents is attained, it is likely that cytotoxic and tissue-
destructive effects greatly predominate. However, in more
peripheral areas of the envenomated tissue, where the
concentration of venom components may be lower,
a mixed response may occur. Thus, some cells may reach
thresholds of cytotoxicity, by either necrosis or apoptosis,
whereas other cell types may not be directly damaged and,
instead, may respond by activation or proliferation. Like-
wise, degradation of extracellular matrix in heavily
damaged regions might be widespread, whereas in other
regions it might give rise to fragments of proteins that may
induce diverse cellular responses. Such integrative scenario
may help to understand the responses associated with
direct and acute tissue damage and those associated with
the onset of processes responsible for tissue repair,
remodeling and regeneration. Consequently, a temporal
and spatial perspective in the tissue response to enveno-
mation has to be considered for an integrated analysis of
local alterations in these pathological models. The study of
venom-induced tissue alterations from this broader
perspective demands novel hypotheses and renewed
research efforts.
11. Beyond tissue damage: reparative and
regenerative events
Acute local pathology after injection of B. asper venom is
characterized, as described above, by prominentmyonecrosis, dermonecrosis, hemorrhage, and damage of
larger vessels, lymphatic vessels and nerves. Such acute
local events are followed by a complex inﬂammatory
reaction, characterized by the inﬁltration of inﬂammatory
cells, mostly neutrophils and macrophages. As a conse-
quence, necrotic tissue is removed and this is followed by
reparative and regenerative processes. The ﬁnal outcome of
local pathology after injection of B. asper venom, and other
viperid snake venoms, may vary from a largely complete
restitution of form and function, in mild and some
moderate cases, to a deﬁcient reparative/regenerative
response that ends up in permanent tissue loss and deﬁ-
cient functional recovery, a common consequence of severe
envenomations (Otero et al., 2002; Gutie´rrez and Lomonte,
2003; Warrell, 2004). Therefore, the analysis of the factors
that mediate tissue repair and regeneration is highly rele-
vant for the design of interventions aimed at promoting
a more successful regenerative response.
11.1. Muscle regeneration is adequate after myotoxin-induced
necrosis but is impaired after venom-induced tissue damage
Whenmice are injected with puriﬁedmyotoxic PLA2s or
PLA2 homologues isolated from B. asper and other Bothrops
sp. venoms, acute muscle necrosis is followed by successful
muscle regeneration (Gutie´rrez et al., 1984c, 1989, 1991).
After necrosis, neutrophils and macrophages inﬁltrate the
tissue and remove the necrotic debris. Concomitantly,
muscle satellite cells, which are myogenic cells present at
the periphery of muscle ﬁbers, within the BM but outside
the myocyte plasma membrane, are activated and become
myoblasts. In addition to satellite cells, myoblasts can also
arise from other non-myogenic cells, such as mesenchymal
stem cells and bone marrow cells (Grounds, 1999).
Myoblasts proliferate, by the action of a variety of media-
tors released in the affected tissue, and eventually they
start a process of cell fusion that ends up with the forma-
tion of multinucleated myotubes (Grounds, 1999). These
proliferative and fusion processes occur within the space
demarcated by the BM of the necrotic muscle ﬁbers, thus
guaranteeing the maintenance of tissue architecture. Upon
the formation of myotubes, these cells mature to become
regenerated adult muscle ﬁbers, although they maintain
the nuclei located in a central position for a prolonged time
span. All these processes are coupled to the regeneration of
neuromuscular junctions (see Harris, 2003 for a discussion
of muscle regeneration after venom PLA2-induced
necrosis). The good regenerative response observed after
injection of myotoxic PLA2s can be explained on the
grounds that the factors required for a successful muscle
regeneration, i.e. adequate blood supply, innervation,
removal of necrotic debris, and permanence of BM, are
fulﬁlled in these conditions (Gutie´rrez et al., 1984c, 1991;
Harris, 2003).
In contrast, when mice are injected with crude B. asper
venom, or puriﬁed hemorrhagic SVMPs, the process of
muscle regeneration is partially impaired (Gutie´rrez et al.,
1984c, 1995b; Arce et al., 1991; Rucavado et al., 1995),
a phenomenon also described for other Bothrops sp.
venoms (Queiroz et al., 1984; Salvini et al., 2001; Santo-
Neto and Marques, 2005). In these conditions, areas of
Fig. 4. Diagramatic summary of the experimental pathogenesis of local tissue damage induced by B. asper venom. The main types of toxins responsible for these
effects are metalloproteinases (SVMPs) and phospholipases A2 (PLA2s) and PLA2 homologues. SVMPs degrade extracelular matrix components and induce
hemorrhage and skin damage (blistering and dermonecrosis). PLA2s and PLA2 homologues, in turn, induce direct damage to the plasma membrane of skeletal
muscle ﬁbers, causing acute myonecrosis, and also damage the walls of collecting lymphatic vessels. Myonecrosis is also provoked by ischemic alterations that
develop secondary to local hemorrhage and to the increment in intracompartmental pressures as a result of extensive extravasation. Both SVMPs and PLA2s
promote the synthesis and/or release of a wide variety of inﬂammatory mediators (kinins, eicosanoids, nitric oxide, cytokines, complement anaphylatoxins,
matrix metalloproteinases, etc.) which induce a strong local inﬂammatory reaction associated with edema and pain (hyperalgesia and allodynia). The effect of
myotoxic PLA2s on collecting lymphatic vessels also contributes to edema.
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tion, revealing an evident delay in the removal of necrotic
debris by phagocytes. In addition, crude venom and iso-
lated hemorrhagic SVMPs drastically affect the microvas-
culature, as revealed by a decrease in the microvascular
density (Gutie´rrez et al., 1984c; Escalante et al., 2006). A
similar scenario has been described after local myonecrosis
induced by B. jararacussu venom (Santo-Neto and Marques,
2005). Moreover, B. asper venom affects intramuscular
nerves (Arce et al., 1991), an observation also performed
with the venom of B. jararacussu (Queiroz et al., 2002). As
a consequence, areas of damaged muscle are replaced by
ﬁbrotic tissue, and even in areas where regenerativemuscle
ﬁbers are observed, they have a small diameter, evidencing
an incomplete regeneration and atrophy (Gutie´rrez et al.,
1984c; Queiroz et al., 1984, 2002; Arce et al., 1991). Inter-
estingly, microscopic observations indicate that some small
regenerative ﬁbers present evidences of degeneration (Arce
et al., 1991), suggesting that these cells may be halted in
their differentiation, probably as a consequence of the lack
of adequate microenvironmental conditions required for
appropriate regeneration.
It has been postulated that such poor regeneration
observed after B. asper venom injection is mostly the
consequence of the drastic effect of venom components in
the microvasculature and intramuscular nerves (Gutie´rrez
et al., 1984c; Arce et al., 1991). This hypothesis is supported
by the observation that inhibition of hemorrhagic activityof B. asper venom signiﬁcantly improves the regenerative
outcome (Gutie´rrez et al., 1986c). In addition, the injection
of a combination of a myotoxic PLA2 and a hemorrhagic
SVMP reproduces the poor regenerative outcome observed
when crude venom is injected (Gutie´rrez et al., 1995b).
Whether this effect induced by hemorrhagic SVMPs
depends on the reduction of blood supply to regenerating
cells, or whether it depends on other actions induced by
SVMPs in the tissue, remains to be investigated. Moreover,
the components that affect intramuscular nerves have yet
to be identiﬁed, together with the analysis of the role of
additional venom components, i.e. hyaluronidases and
other proteinases that affect the extracellular matrix, in the
regenerative process. The understanding of the factors
affecting regeneration in venom-induced myonecrosis may
contribute to the manipulation of such process by the
addition, or inhibition, of tissue mediators, with the aim of
improving the regenerative outcome in patients enveno-
mated by B. asper and other viperid species. Owing to the
effect of SVMPs in the impairment of muscle regeneration,
it is likely that the administration of factors that promote
angiogenesis and revascularization might contribute to
a better regenerative response.
12. Concluding remarks
The complexity of the local pathological changes
induced by the injection of B. asper venom has been
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(Fig. 4). Some basic ideas emerge from this analysis: (a)
Local tissue damage is mainly provoked by the direct action
of venom components in the tissues, especially by the
action of SVMPs in microvessels and extracellular matrix
and of myotoxic PLA2s and PLA2 homologues in skeletal
muscle ﬁbers and lymphatic vessels. The extremely rapid
onset of these effects precludes their neutralization by
antivenoms, especially when there is a delay in antivenom
administration (Gutie´rrez et al., 1998). (b) The tissue
response to the venom goes beyond the direct pathological
effects, as it includes a prominent inﬂammatory response
and the activation of resident and inﬁltrating cells which
synthesize and release a plethora of mediators that inﬂu-
ence the outcome of tissue derangement. Further studies
are required to fully understand the pathogenesis of local
pathology induced by B. asper venom and the role played
by endogenous inﬂammatory and reparative processes in
these alterations.
Such investigations may pave the way for the develop-
ment and application of novel inhibitors that could be
injected at the site of venom injection in ﬁeld conditions,
and which may halt the progression of local tissue damage
by inhibiting SVMPs and PLA2s in situ, rapidly after the bite
(Gutie´rrez et al., 2007). Furthermore, these studies will
identify endogenous inﬂammatory and regenerative events
that can be modulated in order to prevent deleterious
effects of local tissue responses and, at the same time,
promote cellular and tissue processes that result in
improved regeneration (Gutie´rrez et al., 2007). A better
understanding of the local pathology induced by B. asper
venomwill be of value for understanding viperid snakebite
envenomation in general, owing to the common processes
involved in local tissue damage by many viperid species. In
addition, an in-depth understanding of this pathological
model may also contribute to illuminate the processes of
tissue damage from a broader perspective, highlighting
mechanisms involved in tissue pathology and repair in
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